MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 147 filers reported holding MOMENTA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $2,912,000 | +11.6% | 208,729 | +48.0% | 0.01% | 0.0% |
Q3 2017 | $2,609,000 | +15.4% | 141,029 | -9.6% | 0.01% | 0.0% |
Q2 2017 | $2,261,000 | +13.6% | 155,929 | +4.6% | 0.01% | +16.7% |
Q1 2017 | $1,990,000 | +3.4% | 149,029 | +16.5% | 0.01% | -14.3% |
Q4 2016 | $1,925,000 | -29.8% | 127,929 | -45.5% | 0.01% | -30.0% |
Q3 2016 | $2,744,000 | +11.0% | 234,729 | +11.8% | 0.01% | 0.0% |
Q2 2016 | $2,473,000 | +54.1% | 209,929 | +9.9% | 0.01% | +42.9% |
Q1 2016 | $1,605,000 | -43.4% | 191,000 | 0.0% | 0.01% | -41.7% |
Q4 2015 | $2,834,000 | -29.3% | 191,000 | -21.8% | 0.01% | -33.3% |
Q3 2015 | $4,011,000 | -36.9% | 244,400 | -16.5% | 0.02% | -30.8% |
Q2 2015 | $6,361,000 | +263.9% | 292,600 | +192.1% | 0.03% | +271.4% |
Q1 2015 | $1,748,000 | +167.3% | 100,163 | +84.5% | 0.01% | +133.3% |
Q4 2014 | $654,000 | +13.5% | 54,300 | +6.9% | 0.00% | 0.0% |
Q3 2014 | $576,000 | +16.6% | 50,800 | +24.2% | 0.00% | +50.0% |
Q2 2014 | $494,000 | +30.0% | 40,900 | +25.5% | 0.00% | 0.0% |
Q1 2014 | $380,000 | -28.6% | 32,600 | +8.3% | 0.00% | -33.3% |
Q4 2013 | $532,000 | -13.1% | 30,100 | -29.2% | 0.00% | 0.0% |
Q3 2013 | $612,000 | +11.1% | 42,500 | +16.1% | 0.00% | 0.0% |
Q2 2013 | $551,000 | – | 36,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |